메뉴 건너뛰기




Volumn 21, Issue 12, 2005, Pages 1955-1959

The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: A secondary analysis of the MORE trial

Author keywords

Clinical vertebral fracture; Osteoporosis; Postmenopausal; Raloxifene

Indexed keywords

PLACEBO; RALOXIFENE;

EID: 29144479382     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X75032     Document Type: Article
Times cited : (27)

References (22)
  • 1
    • 0036079613 scopus 로고    scopus 로고
    • Review of raloxifene and its clinical applications in osteoporosis
    • Maricic M, Gluck O. Review of raloxifene and its clinical applications in osteoporosis. Expert Opin Pharmacother 2002;3:767-75
    • (2002) Expert Opin Pharmacother , vol.3 , pp. 767-775
    • Maricic, M.1    Gluck, O.2
  • 2
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
    • Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. J Am Med Assoc 1999;282:637-45
    • (1999) J Am Med Assoc , vol.282 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 3
    • 18544381541 scopus 로고    scopus 로고
    • Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    • Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002;87:3609-17
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 3609-3617
    • Delmas, P.D.1    Ensrud, K.E.2    Adachi, J.D.3
  • 4
    • 0037182042 scopus 로고    scopus 로고
    • Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
    • Maricic M, Adachi JD, Sarkar S, et al. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 2002;162:1140-3
    • (2002) Arch Intern Med , vol.162 , pp. 1140-1143
    • Maricic, M.1    Adachi, J.D.2    Sarkar, S.3
  • 5
    • 0027364981 scopus 로고
    • The epidemiology of vertebral fractures [European Vertebral Osteoporosis Study Group]
    • European Vertebral Osteoporosis Study Group
    • Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures [European Vertebral Osteoporosis Study Group]. Bone 1993;14(Suppl 1)S89-S97
    • (1993) Bone , vol.14 , Issue.SUPPL. 1
    • Cooper, C.1    O'Neill, T.2    Silman, A.3
  • 6
    • 0035900949 scopus 로고    scopus 로고
    • Risk of new vertebral fracture in the year following a fracture
    • Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. J Am Med Assoc 2001;285:320-3
    • (2001) J Am Med Assoc , vol.285 , pp. 320-323
    • Lindsay, R.1    Silverman, S.L.2    Cooper, C.3
  • 7
    • 0032524460 scopus 로고    scopus 로고
    • The association of radiographically detected vertebral fractures with back pain and function: A prospective study
    • Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793-800
    • (1998) Ann Intern Med , vol.128 , pp. 793-800
    • Nevitt, M.C.1    Ettinger, B.2    Black, D.M.3
  • 8
    • 0033553866 scopus 로고    scopus 로고
    • Vertebral fractures and mortality in older women: A prospective study
    • Study of Osteoporotic Fractures Research Group
    • Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study [Study of Osteoporotic Fractures Research Group]. Arch Intern Med 1999;159:1215-20
    • (1999) Arch Intern Med , vol.159 , pp. 1215-1220
    • Kado, D.M.1    Browner, W.S.2    Palermo, L.3
  • 9
    • 7944237873 scopus 로고    scopus 로고
    • Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation
    • Grady D, Ettinger B, Moscarelli E, et al., for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Safety and adverse effects associated with raloxifene: Multiple Outcomes of Raloxifene Evaluation. Obstet Gynecol 2004;104:837-44
    • (2004) Obstet Gynecol , vol.104 , pp. 837-844
    • Grady, D.1    Ettinger, B.2    Moscarelli, E.3
  • 10
    • 0027219544 scopus 로고
    • Vertebral fracture assessment using a semiquantitative technique
    • Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48
    • (1993) J Bone Miner Res , vol.8 , pp. 1137-1148
    • Genant, H.K.1    Wu, C.Y.2    Van Kuijk, C.3    Nevitt, M.C.4
  • 11
    • 0038219496 scopus 로고    scopus 로고
    • Cambridge (MA)
    • Anon. StatXact5 user manual. Cambridge (MA):2001;515-7
    • (2001) StatXact5 User Manual , pp. 515-517
  • 12
    • 0031765564 scopus 로고    scopus 로고
    • Updated data on proximal femur bone mineral levels of US adults
    • Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89
    • (1998) Osteoporos Int , vol.8 , pp. 468-489
    • Looker, A.C.1    Wahner, H.W.2    Dunn, W.L.3
  • 13
    • 0141750678 scopus 로고    scopus 로고
    • Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial
    • Delmas PD, Genant HK, Crans G, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 2003;33:522-32
    • (2003) Bone , vol.33 , pp. 522-532
    • Delmas, P.D.1    Genant, H.K.2    Crans, G.3
  • 14
    • 0036851816 scopus 로고    scopus 로고
    • Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the MORE study. Multiple Outcomes of Raloxifene Evaluation
    • Siris E, Adachi JD, Lu Y, et al. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Osteoporos Int 2002;13:907-13
    • (2002) Osteoporos Int , vol.13 , pp. 907-913
    • Siris, E.1    Adachi, J.D.2    Lu, Y.3
  • 15
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
    • Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
    • Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial [Vertebral Efficacy With Risedronate Therapy (VERT) Study Group]. J Am Med Assoc 1999;282:1344-52
    • (1999) J Am Med Assoc , vol.282 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3
  • 16
    • 12944291524 scopus 로고    scopus 로고
    • Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    • Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83-91
    • (2000) Osteoporos Int , vol.11 , pp. 83-91
    • Reginster, J.1    Minne, H.W.2    Sorensen, O.H.3
  • 17
    • 11144354206 scopus 로고    scopus 로고
    • Efficacy of risedronate on clinical vertebral fractures within six months
    • Roux C, Seeman E, Eastell R, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 2004;20:433-9
    • (2004) Curr Med Res Opin , vol.20 , pp. 433-439
    • Roux, C.1    Seeman, E.2    Eastell, R.3
  • 18
    • 0034530951 scopus 로고    scopus 로고
    • Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    • FIT Research Group
    • Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000;85:4118-24
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 4118-4124
    • Black, D.M.1    Thompson, D.E.2    Bauer, D.C.3
  • 19
    • 1642292806 scopus 로고    scopus 로고
    • Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy
    • Delmas PD, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 2004;34:599-604
    • (2004) Bone , vol.34 , pp. 599-604
    • Delmas, P.D.1    Seeman, E.2
  • 20
    • 0036963450 scopus 로고    scopus 로고
    • Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodelling in postmenopausal women with osteoporosis
    • Johnell O, Scheele WH, Lu Y, et al. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodelling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002;87:985-92
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 985-992
    • Johnell, O.1    Scheele, W.H.2    Lu, Y.3
  • 21
    • 0036133366 scopus 로고    scopus 로고
    • Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
    • Riggs BL, Melton LJ, III. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002;17:11-4
    • (2002) J Bone Miner Res , vol.17 , pp. 11-14
    • Riggs, B.L.1    Melton III, L.J.2
  • 22
    • 0141527583 scopus 로고    scopus 로고
    • Is the paradigm shifting?
    • Heaney RP. Is the paradigm shifting? Bone 2003;33:457-65
    • (2003) Bone , vol.33 , pp. 457-465
    • Heaney, R.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.